Cardiff Oncology Inc. buy Global_Player
Start price
17.01.22
/
50%
€6.00
Target price
17.01.23
-
Performance (%)
-44.67%
End price
22.01.22
€3.32
Summary
This prediction ended on 22.01.22 with a price of €3.32. Massive losses of -44.67% were the result for the BUY prediction by Global_Player. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cardiff Oncology Inc. | -6.380% | -6.380% | 180.515% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Global_Player what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Stopped prediction by Global_Player for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
2.28%
27.04.24
27.04.24
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.70
31.08.20
31.08.20
€6.00
03.09.20
03.09.20
-11.94%
03.09.20
03.09.20
Risky Investment